Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Arbutus Biopharma stock have an average target of 4.33, with a low estimate of 4.00 and a high estimate of 5.00. The average target predicts an increase of 38.34% from the current stock price of 3.13.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.00	$4.33	$4.00	$5.00
Change	+27.80%	+38.34%	+27.80%	+59.74%

Analyst Ratings

The average analyst rating for ABUS stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '24	Feb '24	Mar '24	Apr '24	May '24	Jun '24
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5	Strong Buy	Reiterates	$5	+59.74%	Jun 7, 2024
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5	Strong Buy	Reiterates	$5	+59.74%	Jun 6, 2024
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Maintains $4	Strong Buy	Maintains	$4	+27.80%	Jun 5, 2024
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Reiterates $4	Strong Buy	Reiterates	$4	+27.80%	May 3, 2024
Roy Buchanan JMP Securities	JMP Securities	Buy Reiterates $4	Buy	Reiterates	$4	+27.80%	Apr 4, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

6.73M

Decreased by -62.90%

from 18.14M

Revenue Next Year

6.02M

Decreased by -10.51%

from 6.73M

EPS This Year

-0.40

from -0.44

EPS Next Year

-0.40

from -0.40

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	6.01M	6.91M	10.99M	39.02M	18.14M	6.73M	6.02M	8.78M	9.66M	57.78M
Revenue Growth	1.11%	15.02%	58.92%	255.11%	-53.51%	-62.90%	-10.51%	45.69%	10.03%	498.47%
EPS	-2.89	-1.00	-0.83	-0.46	-0.44	-0.40	-0.40	-0.44	-0.19	-0.21
EPS Growth	-	-	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	7	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	10.3M	8.2M	9.0M	9.9M	59.5M
Avg	6.7M	6.0M	8.8M	9.7M	57.8M
Low	4.5M	3.6M	8.4M	9.3M	55.5M

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	-43.3%	21.6%	50.0%	13.3%	516.1%
Avg	-62.9%	-10.5%	45.7%	10.0%	498.5%
Low	-75.2%	-46.1%	40.0%	5.7%	475.0%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	-0.38	-0.36	-0.45	-0.20	-0.22
Avg	-0.40	-0.40	-0.44	-0.19	-0.21
Low	-0.40	-0.42	-0.42	-0.19	-0.21

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	-	-	-	-	-
Avg	-	-	-	-	-
Low	-	-	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.